News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rosetta Genomics Ltd. (ROSG) and Super Religare Laboratories Limited (SRL) Announce Exclusive Distribution Agreement for Rosetta's MicroRNA-based Assays in India, Saudi Arabia, Qatar, and the United Arab Emirates (UAE)


8/19/2009 10:26:51 AM

PHILADELPHIA & NEW DELHI--(BUSINESS WIRE)--Rosetta Genomics, Ltd. (NASDAQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Super Religare Laboratories Limited (SRL), India’s largest diagnostics network, announced today that they have signed an exclusive distribution agreement for Rosetta Genomics’ three currently-available diagnostic tests. Under the terms of the agreement, SRL will market Rosetta Genomics’ miRview™ tests in India, Saudi Arabia, Qatar, and the UAE. Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES